Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation.
暂无分享,去创建一个
[1] M. Drayson,et al. Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation. , 1998, Transplantation proceedings.
[2] P. Mcmaster,et al. Combination treatment effectively intercepts advanced acute cardiac rejection. , 1997, Transplantation proceedings.
[3] D Talbot,et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. , 1997, Transplantation.
[4] R. Guttmann,et al. The effect of transfusion with donor-specific peripheral lymphocytes, whole blood or erythrocytes on cardiac allograft survival in cyclosporine-treated rats. , 1994, Transplantation.
[5] G. Gollin,et al. Prolongation of allograft survival in rat heterotopic heart transplantation by TLCK, a serine protease inhibitor. , 1994, Transplantation.
[6] M. Okuhara,et al. FK 506: historical perspectives. , 1991, Transplantation proceedings.
[7] J. Alexander,et al. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine. , 1991, Transplantation.
[8] J. Bradley. The blood transfusion effect: experimental aspects. , 1991, Immunology letters.
[9] C. Pouteil‐Noble,et al. The value of platelet transfusions as preparation for kidney transplantation. , 1991, Transplantation.
[10] K. Reemtsma,et al. INDUCTION OF DONOR‐SPECIFIC UNRESPONSIVENESS TO RAT CARDIAC ALLOGRAFT BY DONOR LEUKOCYTES AND CYCLOSPORINE , 1988, Transplantation.
[11] K. Wood,et al. PRODUCTION OF INDEFINITE RENAL ALLOGRAFT SURVIVAL IN THE RAT BY PRETREATMENT WITH VIABLE AND NONVIABLE HEPATOCYTES OR LIVER MEMBRANE EXTRACTS1 , 1988, Transplantation.
[12] K. Isono,et al. STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOG , 1987, Transplantation.
[13] Masashi Hashimoto,et al. Structure of FK506, a novel immunosuppressant isolated from Streptomyces , 1987 .
[14] K. Wood,et al. Pretreatment with lymphocyte subpopulations and renal allograft survival in the rat. , 1987, Transplantation.
[15] Wood Ra,et al. Pregraft allogeneic platelets are comparable with pregraft blood in prolonging the survival of rat renal allografts. , 1985 .
[16] H. Schanzer,et al. Long-term prolongation of cardiac allografts by subtherapeutic levels of cyclosporine in rats conditioned with pretransplant blood transfusions and cyclosporine. , 1985, Transplantation.
[17] K. Wood,et al. Suppression of renal allograft rejection in the rat by class I antigens on purified erythrocytes. , 1985, Transplantation.
[18] Z. Varghese,et al. THE ENHANCING AND SENSITIZING EFFECTS OF DONOR BLOOD COMPONENTS, INCLUDING DENDRITIC CELLS, IN A RAT RENAL ALLOGRAFT MODEL , 1984, Transplantation.
[19] B. Kahan,et al. Prolongation of rat kidney allografts by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine. , 1983, Transplantation.
[20] R. Stoney,et al. Deliberate Donor‐specific Blood Transfusions Prior to Living Related Renal Transplantation: A New Approach , 1980, Annals of surgery.
[21] D. Davies,et al. Only B lymphocytes induce active enhancement of rat cardiac allografts. , 1980, Transplantation.
[22] P. Terasaki,et al. Improvement of kidney-graft survival with increased numbers of blood transfusions. , 1978, The New England journal of medicine.
[23] M. R. Mickey,et al. Effect of blood transfusions on subsequent kidney transplants. , 1973, Transplantation proceedings.
[24] P. Morris,et al. THE EFFECT OF DONOR STRAIN BLOOD PRETREATMENT ON RENAL ALLOGRAFT REJECTION IN RATS , 1972, Transplantation.
[25] P. Medawar,et al. ‘Actively Acquired Tolerance’ of Foreign Cells , 1953, Nature.